Search

Issue
Title
Authors
Regional experience of administration of lenvatinib and pembrolizumab combination in patients with disseminated renal cell carcinoma
Kadyrova D.D., Anzhiganova Y.V., Zukov R.A.
Real-world outcomes of lenvatinib plus pembrolizumab in intermediateand poor-risk metastatic renal cell carcinoma
Tsimafeyeu I.V., Sultanbaev A.V., Dubovichenko D.M., Murzalina M.J., Volkov A.A., Orlova R.V., Utyashev I.A., Malina G.D., Gluzman M.I.
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM
Volkova M.I., Abdelgafur A.M., Aivazov M.T., Amoev Z.V., Babina K.G., Borisov P.S., Vorontsovа A.A., Evstigneeva I.V., Evsyukova O.I., Zhelezin O.V., Kalpinsky A.S., Karabina E.V., Kirdakova N.V., Kolesnikov G.P., Kuzmina E.S., Latipova D.K., Leonenkov R.V., Maturov M.R., Meskikh A.V., Mishugin S.V., Ovchinnikova E.G., Olshanskaya A.S., Protsenko S.A., Semiglazova T.Y., Smirnov R.V., Usynin E.A., Fael M.M., Cherniakova E.M., Shumskaya I.E.
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma
Volkova M.I., Kalpinskiy A.S., Goncharova О.A., Menshikov К.V., Stativko O.A., Karabina E.V., Dergunov A.S., Polshina N.I., Aleksandrova E.N., Lebedinets A.A., Panov A.K., Sultanbaev A.V., Usynin E.A., Volkonsky M.V., Mikhalyuk V.V., Zukov R.A., Anzhiganova Y.V., Gusniev M.A., Igumnova E.N., Kuzmicheva S.V., Pokataev I.A., Olshanskaya A.S., Pervakova N.I., Parsadanova E.L., Sannikova T.A., Bystrov A.A., Dubovichenko D.M., Mukhitova M.R., Chubenko V.A., Shkret K.A., Gorshenina M.N., Semenov A.V., Davlatova M.K., Kosareva A.E., Lutoshkina O.A., Maslova O.A., Makhnutina M.V., Mishina A.V., Murzalina M.Z., Podyacheva O.A., Kalinin S.A., Mailyan O.A., Safarova A.R., Semenova K.O., Strokova M.A., Urashkina E.Y., Shmygina O.S., Novikova O.Y.
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA
Alekseev B.Y., Kaprin A.D., Kolesnikov G.P., Mukhomed’yarova A.A., Konopleva E.I., Kalpinskiy A.S.
Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan
Menshikov K.V., Lipatov D.O., Nasretdinov A.F., Musin S.I., Sultanbaeva N.I., Menshikova I.A., Sultanbaev A.V., Izmaylov A.A., Galimov S.N., Rezyapova A.S.
Lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: an initial Russian experience
Volkova M.I., Evsyukova O.I., Olshanskaya A.S., Matveev V.B.
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
Grünwald V., Powles T., Eto M., Kopyltsov E., Rha S.Y., Porta C., Motzer R., Hutson T.E., Méndez-Vidal M.J., Hong S.H., Winquist E., Goh J.C., Maroto P., Buchler T., Takagi T., Burgents J.E., Perini R., He C., Okpara C.E., McKenzie J., Choueiri T.K.
Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress
Kirichek A.A., Kamolov B.S., Matveev V.B.
First experience of using Pembroria® medication in patients with disseminated renal cell carcinoma
Shevchuk I.M., Movchan N.D.
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma
Markova A.S., Matveev V.B.
Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: analysis of the phase 3 randomized CLEAR study
Grünwald V., Powles T., Kopyltsov E., Kozlov V., Alonso-Gordoa T., Eto M., Hutson T., Motzer R., Winquist E., Maroto P., Keam B., Procopio G., Wong S., Melichar B., Rolland F., Oya M., Rodriguez-Lopez K., Saito K., McKenzie J., Porta C.
Targeted therapy of advanced renal cell carcinoma
Popov A.M.
New lenvatinib and pembrolizumab combination for metastatic renal cell carcinoma in 1st line drug treatment: comparative effectiveness and safety
Alekseev B.Y., Shevchuk I.M.
Clinical and economic analysis of effectiveness of Nivolumab (Opdivo®) use as second-line monotherapy in adult patients with advanced renal cell carcinoma after previous systemic therapy
Frolov M.Y., Krysanov I.S., Krysanova V.S.
Combination of lenvatinib and pembrolizumab in treatment of patients with metastatic renal cell carcinoma and factors of poor prognosis
Klimov A.V., Karyakin A.O., Drobot N.T., Gazaryan E.O., Kabardaev R.M., Valiev A.K., Matveev V.B., Averianova S.V.
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study
Volkova M.I., Kalpinskiy A.S., Borisov P.S., Evsyukova O.I., Olshanskaya A.S., Matveev V.B., Alekseev B.Y., Peganova E.V., Nasretdinov A.F., Lymar E.V., Ovchinnikova E.G., Sveklina T.A., Usynin E.A., Abdelgafur A.M., Tararova E.A., Shumova L.M., Belenkov A.S., Dolgov I.Y., Ponomareva N.G., Evstigneeva I.V., Ivanov A.N., Isaev A.R., Leonenkov R.V., Meskikh A.V., Mukhitova M.R., Orlova S.A., Teslenok I.V., Shegurova M.M., Aivazov M.T., Amoev Z.V., Babina K.G., Vorontsova A.A., Karabina E.V., Kirdakova N.V., Shumskaya I.E., Kolesnikov G.P., Kuzmina E.S., Latipova D.K., Lyutova E.S., Fael M.M., Chugarova A.N., Antipin A.S.
1 - 17 of 17 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"